Kyowa Kirin Co., Ltd. (KYKOF)
USD 16.05
(0.0%)
USD 16.05
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 442.23 Billion JPY | 11.01% |
| 2022 | 398.37 Billion JPY | 13.09% |
| 2021 | 352.24 Billion JPY | 10.65% |
| 2020 | 318.35 Billion JPY | 4.1% |
| 2019 | 305.82 Billion JPY | -11.75% |
| 2018 | 346.53 Billion JPY | -1.94% |
| 2017 | 353.38 Billion JPY | 3.02% |
| 2016 | 343.01 Billion JPY | -5.85% |
| 2015 | 364.31 Billion JPY | 9.26% |
| 2014 | 333.44 Billion JPY | -2.1% |
| 2013 | 340.61 Billion JPY | 2.24% |
| 2012 | 333.15 Billion JPY | -3.07% |
| 2011 | 343.72 Billion JPY | -16.92% |
| 2010 | 413.73 Billion JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 392.12 Billion JPY | 10.68% |
| 2007 | 354.27 Billion JPY | 0.24% |
| 2006 | 353.44 Billion JPY | -1.54% |
| 2005 | 358.96 Billion JPY | 2.9% |
| 2004 | 348.83 Billion JPY | -2.91% |
| 2003 | 359.28 Billion JPY | -5.12% |
| 2002 | 378.66 Billion JPY | 0.81% |
| 2001 | 375.61 Billion JPY | 0.19% |
| 2000 | 374.91 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 105.56 Billion JPY | -22.48% |
| 2024 Q2 | 127.4 Billion JPY | 20.68% |
| 2023 Q4 | 136.18 Billion JPY | 27.46% |
| 2023 FY | 442.23 Billion JPY | 11.01% |
| 2023 Q1 | 93.53 Billion JPY | -18.38% |
| 2023 Q3 | 106.84 Billion JPY | 1.11% |
| 2023 Q2 | 105.67 Billion JPY | 12.98% |
| 2022 FY | 398.37 Billion JPY | 13.09% |
| 2022 Q3 | 98.5 Billion JPY | 1.01% |
| 2022 Q4 | 114.59 Billion JPY | 16.34% |
| 2022 Q1 | 87.75 Billion JPY | -10.71% |
| 2022 Q2 | 97.52 Billion JPY | 11.13% |
| 2021 Q3 | 88.94 Billion JPY | 6.01% |
| 2021 FY | 352.24 Billion JPY | 10.65% |
| 2021 Q1 | 81.11 Billion JPY | -3.83% |
| 2021 Q2 | 83.9 Billion JPY | 3.44% |
| 2021 Q4 | 98.27 Billion JPY | 10.49% |
| 2020 Q2 | 80.52 Billion JPY | 4.18% |
| 2020 Q3 | 76.18 Billion JPY | -5.39% |
| 2020 Q4 | 84.34 Billion JPY | 10.71% |
| 2020 Q1 | 77.29 Billion JPY | -3.82% |
| 2020 FY | 318.35 Billion JPY | 4.1% |
| 2019 Q3 | 74.04 Billion JPY | -2.04% |
| 2019 Q1 | 75.83 Billion JPY | -18.12% |
| 2019 FY | 305.82 Billion JPY | -11.75% |
| 2019 Q2 | 75.58 Billion JPY | -0.33% |
| 2019 Q4 | 80.36 Billion JPY | 8.54% |
| 2018 Q2 | 87.39 Billion JPY | 3.16% |
| 2018 FY | 346.53 Billion JPY | -1.94% |
| 2018 Q4 | 92.61 Billion JPY | 13.23% |
| 2018 Q3 | 81.79 Billion JPY | -6.41% |
| 2018 Q1 | 84.72 Billion JPY | -10.76% |
| 2017 Q4 | 94.94 Billion JPY | 12.7% |
| 2017 Q3 | 84.23 Billion JPY | -1.71% |
| 2017 FY | 353.38 Billion JPY | 3.02% |
| 2017 Q2 | 85.7 Billion JPY | -5.75% |
| 2017 Q1 | 90.93 Billion JPY | 6.66% |
| 2016 Q3 | 83.7 Billion JPY | -2.2% |
| 2016 Q1 | 88.46 Billion JPY | -3.18% |
| 2016 Q4 | 85.25 Billion JPY | 1.86% |
| 2016 FY | 343.01 Billion JPY | -5.85% |
| 2016 Q2 | 85.58 Billion JPY | -3.26% |
| 2015 Q2 | 89.23 Billion JPY | -0.4% |
| 2015 FY | 364.31 Billion JPY | 9.26% |
| 2015 Q4 | 91.37 Billion JPY | -2.9% |
| 2015 Q3 | 94.1 Billion JPY | 5.45% |
| 2015 Q1 | 89.59 Billion JPY | -5.2% |
| 2014 Q2 | 75.82 Billion JPY | -11.92% |
| 2014 Q4 | 94.51 Billion JPY | 22.68% |
| 2014 FY | 333.44 Billion JPY | -2.1% |
| 2014 Q3 | 77.03 Billion JPY | 1.61% |
| 2014 Q1 | 86.07 Billion JPY | -2.74% |
| 2013 Q3 | 82.39 Billion JPY | -0.77% |
| 2013 Q2 | 83.03 Billion JPY | -4.19% |
| 2013 FY | 340.61 Billion JPY | 2.24% |
| 2013 Q1 | 86.66 Billion JPY | -2.03% |
| 2013 Q4 | 88.5 Billion JPY | 7.42% |
| 2012 Q3 | 78.4 Billion JPY | -0.98% |
| 2012 Q2 | 79.17 Billion JPY | -9.11% |
| 2012 FY | 333.15 Billion JPY | -3.07% |
| 2012 Q1 | 87.11 Billion JPY | 7.06% |
| 2012 Q4 | 88.46 Billion JPY | 12.84% |
| 2011 Q1 | 114.86 Billion JPY | 5.1% |
| 2011 Q3 | 75.99 Billion JPY | 6.27% |
| 2011 Q2 | 71.5 Billion JPY | -37.75% |
| 2011 FY | 343.72 Billion JPY | -16.92% |
| 2011 Q4 | 81.36 Billion JPY | 7.07% |
| 2010 Q1 | 99.25 Billion JPY | 0.0% |
| 2010 Q3 | 100.98 Billion JPY | -3.09% |
| 2010 Q4 | 109.28 Billion JPY | 8.22% |
| 2010 Q2 | 104.2 Billion JPY | 4.99% |
| 2010 FY | 413.73 Billion JPY | 0.0% |
| 2009 Q2 | 96.81 Billion JPY | 0.0% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q3 | 97.57 Billion JPY | 0.79% |
| 2008 Q2 | 125.43 Billion JPY | 0.0% |
| 2008 Q3 | 122.33 Billion JPY | -2.47% |
| 2008 FY | 392.12 Billion JPY | 10.68% |
| 2007 FY | 354.27 Billion JPY | 0.24% |
| 2006 FY | 353.44 Billion JPY | -1.54% |
| 2005 FY | 358.96 Billion JPY | 2.9% |
| 2004 FY | 348.83 Billion JPY | -2.91% |
| 2003 FY | 359.28 Billion JPY | -5.12% |
| 2002 FY | 378.66 Billion JPY | 0.81% |
| 2001 FY | 375.61 Billion JPY | 0.19% |
| 2000 FY | 374.91 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AstraZeneca PLC | 46.91 Billion USD | -842.632% |
| Bristol-Myers Squibb Company PFD CONV 2 | 45 Billion USD | -882.609% |
| CSPC Pharmaceutical Group Limited | 31.45 Billion USD | -1306.141% |
| Clarus Therapeutics Holdings, Inc. | 13.95 Million USD | -3168439.084% |
| Novartis AG | 46.66 Billion USD | -847.778% |
| PT Kalbe Farma Tbk. | 1.97 Billion USD | -22244.099% |